Orbimed Capital established new holdings in Prelude Therapeutics Incorporat

This post was originally published on this site

https://i-invdn-com.akamaized.net/news/LYNXNPEB6J0AJ_M.jpg

Orbimed Capital’s holding in Prelude Therapeutics Incorporat established a new holding of about 917 thousand shares with the purchase.